MDEV
First Trust Exchange-Traded Fund VI - First Trust Indxx Medical Devices ETFBATS
Updated 1 day ago
Coverage limited
$21.16+0.37%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- +4.2%
- 3 months
- +7.7%
- 1 year
- +2.2%
- 52-week range
- $17.85$21.81
- Dividend
- No dividends on record
- Short interest
- 312 sharessettled Sep 30, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if MDEV is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: UNKNOWN
0 top institutions tracked
as of 2023-Q4 (filed 2024-02-14)
Note: 13F filings are reported up to 45 days after quarter-end.Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
6 filers reported a long position in MDEV for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Cetera Investment Advisers | $698.2K | 36.5K | New |
| JANE STREET GROUP, LLC | $252.7K | 13.2K | -58.9% |
| Regatta Research & Money Management | $191.2K | 10K | — |
| OSAIC HOLDINGS, INC. | $21.2K | 1.1K | Unchanged |
| Keating Financial Advisory Services, Inc. | $5.4K | 283 | +13.2% |
| UBS Group AG | $364 | 19 | +111.1% |
Get the Full Analysis for MDEV
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.